Oncology Brand-Generic
Terms
undefined, object
copy deck
- Emend
-
Aprepitant/fosaprepitant
Supportive care - Zofran
-
Ondansetron
Supportive care - Kytril
-
Granisetron
Supportive care - Anzemet
- Dolasetron
- Aloxi
-
Palonosetron
Supportive care - Morphine ER
-
MS Contin, Oramorph SR - q8-12hr
Kadian, Avinza - q24h - Oxycodone ER
- Oxycontin - q8-12hr
- Duragesic
-
Transdermal Fentanyl
q48-72hours - Procrit
- Recombinant human erythropoieten alpha
- Aranesp
- Darbepoetin
- Filgrastim
-
Neupogen
G-CSF - Pegfilgrastim
-
peg G-CSF
Neulasta -
Leukine
GM - CSF - Sargramostim
- Velcade
- Bortezomib IV
- Torisel
- Temsirolimus IV TKI
- Rituxan
- Rituximab
- Mylotarg
- Gemtuzumab
- Campath
- Alemtuzumab
- Zevalin
- Ibritumumab
- Bexxar
- Tosituzumab
- Arzerra
- Ofatumumab
- Herceptin
- Trastuzumab
- Avastin
- Bevacizumab
- Erbitux
- Cetuximab
- Vectibix
- Panitumumab
- Gleevec
- Imatinib
- Sprycel
- Dasatinib
- Tasigna
- Nilotinib
- Tarceva
- Erlotib
- Nexavar
- Sorafenib
- Sutent
- Sunitinib
- Votrient
- Pazopanib
- Tykerb
- Lapatinib
- Bulinent
- Burlinib
- BSA
- Square root of [(ht in cm)(weight in kg)/3600]
- Xeloda
- Capecitabine
- Eloxatin
- Oxaliplatin
-
Camptosar
cpt-11 - Irinotecan
- Taxol
- Paclitaxel
- Taxotere
- Docetaxel
- Oncovin
- Vincristine
- Navelbine
- Vinorelbine
- Velban
- Vinblastine
- Camptosar
- Irinotecan
- VePesid
- Etoposide
- Alimta
- Pemetrexed
- Iressa
- Gefitinib
- Faslodex
- Fulvestrant
- Ixabepilone
- Epothilone
- Tam
- Tamoxifen
- Arimidex
- Anastrozole
- Femara
- Letrozole
- Aromasin
- Exemestane
- AC
- doxorubicin/cyclophosphamide
- TAC
- doxorubicin/cyclophosphamide/docetaxel
- TC
- docetaxel/cyclophosphamide
- AC-TH
- AC with trastuzumab
- TCH
- docetaxel/carboplatin/trastuzumab
- Abraxane
- Paclitaxel albumin bound
- Ixempra
- Ixabepilone
- Zometa
- Zolendronate
- CrCl - Cockcroft Gault
- (140-age)x (wt in kg) / (72xSCr) x0.85 for female